On behalf of the World Federation of Haemophilia (WFH) Congress Program Committees, it is our great pleasure to invite you to attend the WFH 2018 World Congress in Glasgow, Scotland.
The WFH World Congress is unique because the entire global bleeding disorders community participates. Patients and families, WFH national member organizations, physicians and other health care providers, and regulators representing the whole community will all be present.
The Congress program will feature internationally recognized experts in haemophilia care and research from more than 100 countries. Speakers will present and discuss the latest topics and advances in the management and treatment of people with inherited bleeding disorders, focusing on strategies, experiences and techniques supporting the global efforts of the WFH. Having planned many important sessions covering a wide range of topics, we believe there will be something for everyone.
General plenaries. In addition to the President’s and VP Medical plenaries, we have prepared general plenaries on gene therapy and also on new structured research strategies for inhibitors.
Medical plenaries. Keeping in mind the need for comprehensive insight on the latest developments in healthcare, we have also put together an overview of emerging therapies, a discussion on models of prophylaxis in the developing world, lessons learned from other inherited bleeding disorders, and case reports on gene therapy.
Multidisciplinary plenaries. Along with medical plenaries, the WFH 2018 World Congress will feature parallel plenary sessions to provide participants with new insights and valuable information on the current understanding of pain, using the patient’s voice, women’s perspectives, and transitioning techniques.
Medical topics. Building on the success of previous WFH World Congress, we have assembled a thought provoking medical program featuring sessions such as New Treatment Options Including Gene Therapy, Implications of Altering the Haemostatic Balance, and Bleeding Disorders in the Genomics Era, among many others.
Multidisciplinary topics. A wide range of sessions have been developed for participants with multidisciplinary interests, ranging from topics such as Bleeding Disorders and Digital Technologies, to Treating and Bleeding: Healthcare Professionals Living with a Bleeding Disorder.
Professional development workshops. We would like to encourage you to attend our professional development workshops and be part of the conversations and debates that are part of the session experience.
The Congress program provides a wonderful opportunity for participants to exchange ideas and experiences. Similarly, patients will have the chance to interact with support networks from many different bleeding disorders communities from around the world.
We look forward to welcoming old friends and meeting new ones in Glasgow.
Abstract Submission Guidelines
Abstract submission deadline November 17, 2017, 11:59 pm EST
Notification to authors December 18 to 22, 2017
Abstract presenter registration deadline March 23, 2018
Rules for authors
• The abstracts must not have been published before. Note that selected abstracts will be published as a supplement in Haemophilia journal, the official Congress Book of Abstracts.
• Rule of Two: Each author may present a maximum of two abstracts at the Congress. However, authors can make an unlimited number of submissions. Should an author have more than two abstracts accepted, a co-author must be named as the presenting author for the third or more abstracts.
• All presenting authors must be paid registrants of the WFH 2018 World Congress by March 23, 2018, for regular abstracts and April 20, 2018, for late-breaking abstracts. After this date, presenting authors who have not paid their registration fees will be excluded from the program, as well as from the Book of Abstracts.
• The submission of an abstract carries with it the obligation that it will be presented at the Congress by the presenting author. Failure to present as scheduled may result in the non-acceptance of future submissions at WFH meetings.
• Each abstract will be blinded and scored by three reviewers. Abstracts will be accepted based on the following criteria: relevance; interpretation of results; originality and novelty; organization; and clarity.
• Abstracts may not be revised or resubmitted after the deadline date of November 17, 2017.
• Please submit abstract withdrawal requests in writing by March 23, 2018.
• Please submit change of presenting author requests in writing by March 23, 2018. After this date, changes will not appear in the Book of Abstracts.